Search This Blog

Thursday, November 7, 2019

Global Blood Therapeutics EPS misses by $0.01

Global Blood Therapeutics (NASDAQ:GBT): Q3 GAAP EPS of -$1.07 misses by $0.01.
Cash, cash equivalents and marketable securities of $683.1M.
Shares +0.65% AH.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)